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.2013.02.Abstract Objective: We conducted this clinical study to assess the adjuvant effects of single dose
magnesium sulfate (Mg) when administered epidurally during labor with fentanyl and bupivacaine.
Methods: Eighty healthy nulliparous women in labor requesting epidural analgesia were divided
into two groups. Group 1 received bupivacaine 0.125% with magnesium sulfate 50 mg and fentanyl
50 lg as a loading dose; group 2, received bupivacaine 0.125% and fentanyl 50 lg only. Hemody-
namic parameters, motor and sensory evaluation, cervical dilation at time of consenting, the pro-
gress of labor, the visual analog pain score (VAS), Apgar score, cord blood acid base status, side
effects as nausea, vomiting, itching and respiratory depression were recorded. Fetal heart rate trac-
ings were also documented.
Results: Epidural single dose magnesium sulfate added to bupivacaine and fentanyl in labor
resulted in signiﬁcantly faster onset and longer duration of epidural analgesia (169 ± 50 min) in
comparison to those patients who received bupivacaine and fentanyl only (105 ± 41 min), also
there was a signiﬁcant reduction in the number of women requiring additional boluses of bupiva-
caine when Mg was added (P= 0.016). The two groups had no signiﬁcant differences as regards
maternal satisfaction score, maternal and neonatal adverse effects.
Conclusion: Magnesium sulfate added to bupivacaine and fentanyl for labor epidural analgesia
resulted in faster onset, longer duration of action and reduced the break through pain.
ª 2013 Egyptian Society of Anesthesiologists. Production and hosting by Elsevier B.V.
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0021. Introduction
Epidural analgesia using local anesthetics is the best method
for painless labor, because of its effective pain relief, less
maternal stress response, better parturient satisfaction, and
the ability to provide anesthesia. The quality of analgesia is
better with the combined use of a local anesthetic and an opi-
oid. However, clinical trials aiming to minimize the side effectsosting by Elsevier B.V. Open access under CC BY-NC-ND license.
220 R. Hasanein et al.related to epidural local anesthetic administration as motor
impairment and sympathetic blockade were and still need to
be done [1–4].
Magnesium, the fourth most common cation in the body,
has postsynaptic N-methyl D-aspartate (NMDA) calcium
channel blocker properties, and has been used successfully to
potentiate opioid analgesia and to treat neuropathic pain in
animals [5]. Tramer et al. did the ﬁrst clinical study demon-
strating that the administration of magnesium sulfate in the
perioperative period was associated with less analgesic require-
ments in the postoperative period [6]. Other studies examined
different routes of magnesium administration such as the intra-
venous or the intrathecal route, and were found to improve
anesthetic and analgesic quality [7]. Epidural magnesium was
found to reduce the use of postoperative analgesia without in-
creases in side effects [8,9].
The addition of magnesium to spinal bupivacaine–fentanyl
anesthesia improves the duration of spinal analgesia for labor
without any side effects [10].
The addition of magnesium to epidurally administered
bupivacaine and fentanyl in patients undergoing elective cesar-
ean section with combined spinal-epidural anesthesia helped to
improve the quality of postoperative analgesia [11].
To our knowledge, there were no previous clinical studies
which examined the effect of magnesium sulfate administered
epidurally as an adjunct to epidural bupivacaine and fentanyl
in labor. Therefore, we conducted this clinical study to deter-
mine the effects of adding single dose of magnesium sulfate
to epidural bupivacaine and fentanyl for labor analgesia.2. Material and methods
After approval of the Ethics Committee and obtaining in-
formed written consent, we studied 80 healthy (ASA physical
status I or II) nulliparous women in active labor. This study
was conducted at Saad Specialist Hospital, Saudi Arabia, in
the period between January 2010 till January 2012. Women
requesting epidural analgesia were considered for inclusion in
this study if they presented with a single pregnancy of more
than 37 weeks gestation, in early labor (cervix dilation
<5 cm) with normal fetal heart rate. Excluded patients in-
cluded those with pregnancy-induced hypertension, multiple
or high risk pregnancies, breech presentation, multiparty,
and gestational diabetes.
Patients were randomly allocated into one of two groups.
Group 1 received: 8 mL of bupivacaine 0.125%, Mg sulfate
50 mg (0.5 mL of 10% solution), fentanyl 50 lg (1 mL); group
2 received: 8 mL of bupivacaine 0.125%, fentanyl 50 lg (1 mL)
and 0.5 mL normal saline. Randomization was performed by
random computer allocation with numbered envelopes. The
syringe was prepared by a technician anesthetist who was
not involved in the study at the time of randomization. Place-
ment and management of the epidural labor analgesia, and
data recordings were done by an anesthesia team who was
blinded to group allocation.
Intravenous ﬂuid loading with 500 mL of Ringer’s lactate
solution was given. Patients were then placed in the sitting po-
sition, and local anesthesia inﬁltration of skin and subcutane-
ous tissues was done at the level of L2–3 or L3–4 with 2–3 mL
of lidocaine 2%. Then, the epidural space was localized with
the loss of resistance to air technique using an 18-gauge Tuohyneedle. A 20-gauge multi-oriﬁce epidural catheter was then in-
serted 4 cm into the epidural space in a cephalic direction and
aspirated for detection of cerebrospinal ﬂuid or blood. After
the catheter was ﬁxed, patients were repositioned with left
uterine displacement, and 3 mL of 2% lidocaine with 15 lg
of epinephrine as a test dose was injected. In the absence of
intravascular or intrathecal placement of the catheter, the
study drug was injected 5 min after the test dose.
The time of the injection of study drug was considered as
T= 0 and assessments were done accordingly. Pain was as-
sessed with a 10-cm linear visual analog scale (VAS) immedi-
ately before epidural placement and at 5, 10, 15, 30, 60, 120,
180, and 240 min after injection of the study drug. Onset of
analgesia was considered as time to achieve VAS 6 3. Dura-
tion of analgesia was taken as time between T= 0 and break-
through pain, which was deﬁned as VAS > 3, or request for
additional analgesia and treated in a similar way in all groups.
Management of breakthrough pain was done by a bolus of
8 mL of bupivacaine 0.125% followed by a continuous infu-
sion of bupivacaine 0.125% and fentanyl 2 lg/mL at rate of
10 mL/h and additional top-up doses of 6–8 mL of bupiva-
caine 0.125% if required.
A maximum of three top-up doses in the ﬁrst 4 h of the
study was given before exclusion of the case from the study.
On the ﬁrst postpartum day, maternal satisfaction was as-
sessed with a 10-cm VAS by an observer blinded to the study
drug, 10 being very satisﬁed.
Sensory levels were checked with changes to cold (ice) at 5,
10,15,30,60, 120, 180, and 240 min after study drug injection.
Motor block using a modiﬁed Bromage scale (0 = no block,
1 = inability to raise extended leg, 2 = inability to ﬂex knee,
and 3 = inability to ﬂex ankle and foot) were also recorded
at the same time intervals. With a Bromage scoreP2, the infu-
sion rate of bupivacaine was reduced until the Bromage score
was found to be 61. Maternal monitoring included arterial
blood pressure and continuous heart rate recording. Cervical
dilation at entry of study, duration of ﬁrst and second stages
of labor was recorded. Hemodynamic parameters, motor,
and sensory assessments were discontinued after 4 h, but
recording of total and hourly administration of the drugs
was continued until delivery. Side effects, such as nausea, vom-
iting, itching, sedation, bradycardia or hypotension were re-
corded. Hypotension was deﬁned as systolic blood pressure
measurement <100 mmHg and/or P25% baseline decrease
and was treated with 5–10 mg of ephedrine and additional
doses if needed.
Fetal heart rate was continuously recorded on a cardiotoco-
graph (Hewlett–Packard 80300A, Hewlett Packard, Palo Alto,
CA), and were monitored by obstetricians who were blinded to
group allocation and rechecked again postpartum for detec-
tion of fetal heart rate abnormalities. Analysis compared trac-
ings obtained at least 30 min before epidural and recorded
during epidural analgesia. Fetal heart rate abnormalities such
as late decelerations, bradycardia (deﬁned as fetal heart rate
<100 bpm lasting for 5 min or more), and decreased fetal
heart rate variability (at least two accelerations of 15 bpm last-
ing 15 s for 40 min) were noted. Fetal conditions were man-
aged according to the situation by oxygen, left or right
lateral uterine displacement, ephedrine if needed, cessation of
oxytocin, and possible tocolytic treatment, umbilical cord
blood–gas were also recorded. Apgar scores at 1, 5 and
10 min were also recorded. Clinical evaluation at 24 h after
Table 1 Demographic data and progress of labor in both groups.
Group 1 (n= 38) Group 2 (n= 40) P value
Age (years) 26.2 ± 2.3 25.3 ± 2.5 0.103
Weight (kg) 73 ± 3.6 75 ± 6.3 0.091
Height (cm) 157 ± 7 161 ± 3 0.001*
Gestational age (weeks) 39 ± 1.5 39 ± 2.1 1.00
Cervical dilatation (cm) 4.2 ± 0.8 4.6 ± 1.1 0.071
Duration of the 1st stage (min) 213 ± 110 229 ± 103 0.509
Duration of the 2nd stage (min) 110 ± 29 120 ± 21 0.084
Values are presented as mean ± SD.
* P value <0.05.
Table 2 Analgesia characteristics and satisfaction score.
Group 1 (n= 38) Group 2 (n= 40) P value
VAS before the epidural 8.8 ± 1.1 9.0 ± 1.3 0.467
VAS at 5 min 6.4 ± 2.47 6.6 ± 1.3 0.075
Patients with VAS 6 3 at 5 min (n, %) 4 (10.5%) 5 (12.5%) 0.935
VAS at 10 min 4.1 ± 1.6 6.3 ± 1.3 <0.01*
Patients with VAS 6 3 at 10 min (n, %) 18 (47.4%) 10 (25%) 0.040*
VAS at 30 min 0.5 ± 2 2.5 ± 0.3 <0.01*
Patients with VAS 6 3 at 30 min (n, %) 38 (100%) 34 (85%) 0.039*
Top-up doses in 4 h (mg) 5.2 ± 6.5 9.7 ± 6.9 0.004*
Analgesia duration (min) 169 ± 50 105 ± 41 <0.01*
Satisfaction score 8.6 ± 1.2 8.2 ± 0.8 0.086
Data are presented as mean ± SD, number of patients or percentage.
* P< 0.05.
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group allocation.
2.1. Statistical analysis
Data were statistically described in terms of mean ± standard
deviation (±SD), or frequencies (number of cases) and per-
centages when appropriate. Comparison of numerical vari-
ables between the study groups was done using Student t test
for independent samples. For comparing categorical data,
Chi square (v2) test was performed. Yates correction equation
was used instead when the expected frequency is less than 5. P
values less than 0.05 was considered statistically signiﬁcant. All
statistical calculations were done using computer programs
SPSS (Statistical Package for the Social Science; SPSS Inc.,
Chicago, IL, USA) version 15 for Microsoft Windows.Figure 1 The number of women requiring additional boluses of
bupivacaine during the 4 h of the study: \P< (0.016).3. Results
Eighty women were included in this study; two patients were
excluded as one delivered by cesarean section due to failure
to progress, and the other one required replacement of the
catheter in the 2nd hour due to catheter displacement. Both
groups were comparable regarding demographic data, cervical
dilation upon entry, and duration of ﬁrst and second stages,
although there was statistically signiﬁcant difference in the
height (P= 0.001) between both groups, but this difference
was not clinically signiﬁcant (Table 1).
The onset of analgesia was shorter in group 1, VAS becom-
ing signiﬁcantly less at 10 min (Table 2). At 10 and 30 min the
number of patients having pain score < or =3 was signiﬁ-cantly higher in group 1 than in group 2 (Table 2). Duration
of analgesia was signiﬁcantly prolonged with the addition of
magnesium sulfate, (169 ± 50) min in comparison to only
(105 ± 41) min in group 2 (Table 2).
The number of patients requiring additional boluses of
bupivacaine during the 4 h of the study is represented in
Fig. 1. The additional bolus dose was (bupivacaine 0.125%
6–8 mL). After the start of the study 21 patients in group 1 re-
quired no additional doses during 4 h study, versus 10 patients
in group 2, which was signiﬁcantly different (P value 0.016),
while 14 patients in group 1 versus 21 patients in group 2 re-
quired only one additional bolus dose (P value 0.165), and 3
patients in group 1 versus 9 patients in group 2 required more
than one bolus dose (P value 0.141) (Fig. 1).
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Figure 2 Changes in maternal heart rate (MHR), maternal
blood pressure (MBP), and fetal heart rate (FHR) in each group.
222 R. Hasanein et al.Although there was a tendency at higher satisfaction score
in group 1 in the 1st postpartum day, there was no statistically
signiﬁcant difference between the two groups; group 1:
(8.6 ± 1.2) versus (8.2 ± 0.8) in group 2, (P value 0.086).
3.1. Maternal data
Maternal hemodynamic data are shown in Fig. 2. There was
no signiﬁcant difference in maternal MAP, HR, and neonatal
HR between the two groups at any time points (P> 0.05).3.2. Side-effects
Although no signiﬁcant difference was seen, there was a trend
that the incidence of side-effects (pruritus and shivering) was
higher in group 2. No signiﬁcant difference was observed in
other side-effects such as nausea, vomiting, motor block, respi-
ratory depression, and hypotension between the two groups.
Furthermore, none of the parturient in both group required
certain treatment during labor (Table 3).
3.3. Neonatal data
Neonatal data are presented in (Table 4). Umbilical arterial
blood pH, umbilical arterial blood oxygen partial pressure,
arterial blood carbon dioxide partial pressure and base deﬁcit,
lactate concentrations, and Apgar scores at 1, 5 and 10 min
were comparable between the two groups. Although the neo-
natal birth weight was signiﬁcant statistically between both
groups but clinically it was within the normal range.
4. Discussion
This study demonstrated the additive analgesic effect of epidu-
ral magnesium sulfate, administered with bupivacaine and
fentanyl.
In our study, onset of analgesia was shorter among patients
receiving magnesium sulfate. We deﬁned good analgesia as a
VAS 6 3 and recorded VAS at 5 and 10 min to determine
the number of cases reporting VAS scores 63 at these time
intervals. Our results showed that the addition of magnesium
has an effect both on the number of women with a VAS 6 3
and on the mean VAS at 10 min. Also, the addition of magne-
sium to 0.125% bupivacaine prolonged the analgesia by
approximately 1 h; (169 ± 50 min) versus (105 ± 41 min) in
the group received magnesium and the group who did not re-
ceive magnesium respectively. Also, the break through pain
and the top up doses needed in 4 h were reduced signiﬁcantly
by adding magnesium to epidural bupivacaine and fentanyl.
A study was done to determine the effects of adding magne-
sium sulfate to epidural bupivacaine and fentanyl in patients
undergoing elective caesarean section using combined spinal-
epidural anesthesia, patients who received magnesium had
good intraoperative conditions as well as good quality of post-
operative analgesia [12].
Magnesium was compared with clonidine, as an adjuvant
to epidural bupivacaine in lower abdominal and lower limb
surgeries. Rapid onset of surgical anesthesia without any
side-effects occurred with magnesium concluding that magne-
sium may be a good alternative to epidural bupivacaine [13].
Noxious stimulation causes the release of neurotransmit-
ters, which attach to different amino acid receptors, including
NMDA receptors, Stimulation of these receptors results in en-
try of calcium into the cell and causes a series of central sensi-
tization and long-term potentiation in the spinal cord [14].
Excitation of NMDA receptor may be of value in determining
the duration of acute pain [15]. Therefore, antagonists of
NMDA receptor help in the prevention and treatment of
post-traumatic pain [16]. Non-competitive NMDA receptor
antagonists have an effect on pain when used alone, but it
has also been shown that they can have the analgesic proper-
ties of opioids [17,18]. In this way, the injection of both mag-
Table 3 Maternal data in both groups.
Group 1 (n= 38) Group 2 (n= 40) P value
Pruritus (n, %) 1 (2.6%) 3 (7.5%) 0.645
Nausea (n, %) 3 (7.9%) 4 (10%) 0.943
Vomiting (n, %) 1 (2.6%) 2 (5%) 0.964
Hypotension (n, %) 3 (7.8%) 4 (10%) 0.531
Respiratory depression (n) 0 0 1.000
Bromage scale (n): 0, 1, 2, 3 37, 1, 0, 0 33, 5, 2, 0 0.089
Values are presented as number or percentage.
Table 4 Neonatal data in both groups.
Group 1 (n= 38) Group 2 (n= 40) P value
Birth-weight (kg) 3.3 ± 0.4 3.5 ± 0.3 0.014*
Apgar score at: 1, 5 and10 min <7 0/0/0 0/0/0 1.000
Umblical arterial blood acid–base status
pH 7.37 ± 0.03 7.37 ± 0.03 1.000
PO2 (mmHg) 15.2 ± 4.2 15.0 ± 2.2 0.791
PCO2 (mmHg) 52 ± 5 53 ± 2 0.245
Base excess (mmol/L) 3.20 ± 2.4 3.03 ± 2.5 0.760
Lactate concentration (mmol/L) 4.1 ± 1.3 4.3 ± 1.1 0.456
Values are presented as mean ± SD.
* P value <0.05.
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tion in opioid administration for postoperative pain relief.
Many studies showed that systemic administration of magne-
sium is accompanied by reduction in analgesic requirement
and less postoperative pain [15,19]. The proper mechanism
of the interaction between the NMDA receptor complex and
opioid anti-nociception has not been cleared, but it has been
shown that magnesium supplement helps the analgesic effect
of opioids and delays the development of tolerance [18,20].
No study showed the physicochemical properties of magne-
sium in relation to its penetration to the spinal meninges, but
there may be a mechanism for epidural usage, which may be
related to its diffusion from the dura mater.
In our study, epidural administration of magnesium had an
additive analgesic effect to bupivacaine and fentanyl during la-
bor analgesia, in comparison with the bupivacaine fentanyl
only.
In two cases reported by Goodman et al. [21], larger doses
(8.7 g, 9.6 g) of magnesium sulfate were accidentally adminis-
tered into the epidural space and did not result in any neuro-
logic complication. Also another report showed that an
accidental intrathecal injection of 1000 mg of magnesium re-
sulted in a transient motor block followed by a complete reso-
lution with no neurological complication at long-term follow-
up [22].
We reported neither episodes of maternal bradycardia nor
sedation in either group probably due to small dose of opioid
used in both groups.
In our study the addition of magnesium sulfate to epidural
bupivacaine and fentanyl did not seem to impact fetal heart
rate or fetal outcome, as monitored by Apgar scores and
umbilical cord blood–gas values.
In other studies, it was reported that the addition of intra-
thecal magnesium 50 mg to spinal anesthesia is safe and pro-longs the period of anesthesia without additional side-effects
[20,23].
Also, Banwait and colleagues had evaluated the effect of
single epidural bolus dose of magnesium when added to epidu-
ral fentanyl for postoperative analgesia in 60 patients under-
went total hip replacement under combined –spinal epidural
anesthesia and they concluded that; the administration of epi-
dural magnesium (75 mg) with epidural fentanyl (1 lg/kg) for
postoperative analgesia resulted in signiﬁcantly increased
duration of analgesia when compared with epidural fentanyl
(1 lg/kg) alone and that the addition of magnesium reduces
the requirement of breakthrough analgesics with no increased
incidence of side effects [24].
The concern of neuromuscular blockade after intravenous
injection of magnesium is emphasized in the literature [25],
but no effect was noted on motor function in our study (as
tested by modiﬁed Bromage score) when magnesium was
administered epidurally.
Magnesium role in preventive analgesia was studied in pa-
tients underwent abdominal hysterectomy by continuous infu-
sion of magnesium sulfate epidurally before the start of
anesthesia and it was found to provide an analgesic-sparing ef-
fect which improved the postoperative analgesia in a time per-
iod that exceeded ﬁve half-lives of the drug without any
increase in the adverse effects [26].
In conclusion, single dose epidural magnesium is a useful
adjuvant to bupivacaine 0.125% and fentanyl in labor epidural
analgesia. Further studies should point to different dosages of
magnesium and different surgical settings.
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